Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|3|380-392

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.3, 2011-03, pp. : 380-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-01 ,pp. : 223-229

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products

By  

Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. : 973-981

Bentham Science Publishers

Access to resources Recommend Favorite

Fas ligand: a potential target for therapeutic induction of apoptosis and enhancing immunotherapy in cancer

By O'Connell J.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 601-611

Informa Healthcare

Access to resources Recommend Favorite

Lysine-specific demethylase 1 as a potential therapeutic target

By Stavropoulos Pete   Hoelz André  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 809-820

Informa Healthcare

Access to resources Recommend Favorite

FOXP1: a potential therapeutic target in cancer

By Koon Henry B   Ippolito Gregory C   Banham Alison H   Tucker Philip W  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 955-965

Informa Healthcare

Access to resources Recommend Favorite